Suggested reading from critics and editors at The New York Times.

Q4 2024 Earnings Call Transcript March 17, 2025 Operator: Good morning, ladies and gentlemen, and welcome to the NRx ...

Below is a roundup of health tech and digital health news you may have missed | Keep up with some of the latest headlines in ...

Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals 4Q and full year 2024 earnings call. At this time, all lines are in a listen only mode. Following the presentation, we will ...

Following claims by the National Agency for Food and Drug Administration and Control that the Southeast region accounts for 60 per cent of kidney and heart-related diseases, UCHE OKERE speaks with a ...

This was how Senate Majority Leader Francis ‘Tol’ Tolentino described the submission by the Philippine government of the ‘Talampas ng Pilipinas’ chart to the International Seabed Authority (ISA).

A study published in Life Metabolism examined the effects of intermittent fasting on components of blood clotting. Researchers, using 160 study participants, human ... M.D., Ph.D “Conversely ...

Frequent blood donors may be getting more than a warm, fuzzy feeling from their altruism, as giving blood may also enhance your ability to produce healthy blood cells, potentially reducing the ...

Read on to learn more about blood glucose levels by age with a chart offering glucose level guidance, as well as other factors that may influence your glucose levels. The 2025 standards of care ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The drug significantly improved blood glucose control and boosted heart and liver health. Larger clinical studies are pending. Berberine is a naturally occurring alkaloid found in various plants.

Barclays analyst Julian Mitchell maintained a Buy rating on Parker Hannifin (PH – Research Report) today and set a price target of $750.00. The company’s shares closed yesterday at $624.72.